These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7916292)

  • 1. Neuropeptide Y and energy balance: one way ahead for the treatment of obesity?
    Dryden S; Frankish H; Wang Q; Williams G
    Eur J Clin Invest; 1994 May; 24(5):293-308. PubMed ID: 7916292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hypothalamus and obesity.
    Harrold JA; Halford JC
    Recent Pat CNS Drug Discov; 2006 Nov; 1(3):305-14. PubMed ID: 18221212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer.
    Zhang L; Bijker MS; Herzog H
    Pharmacol Ther; 2011 Jul; 131(1):91-113. PubMed ID: 21439311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis.
    Tomaszuk A; Simpson C; Williams G
    Horm Res; 1996; 46(2):53-8. PubMed ID: 8871182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central control of feeding behavior by neuropeptide Y.
    Zimanyi IA; Fathi Z; Poindexter GS
    Curr Pharm Des; 1998 Aug; 4(4):349-66. PubMed ID: 10197048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptide Y, the hypothalamus, and diabetes: insights into the central control of metabolism.
    Frankish HM; Dryden S; Hopkins D; Wang Q; Williams G
    Peptides; 1995; 16(4):757-71. PubMed ID: 7479313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NPY and energy homeostasis: an opportunity for novel anti-obesity therapies.
    MacNeil DJ; Kanatani A
    EXS; 2006; (95):143-56. PubMed ID: 16383004
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurobiology.
    Wilding J; Widdowson P; Williams G
    Br Med Bull; 1997; 53(2):286-306. PubMed ID: 9246837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine administration reduces neuropeptide Y and neuropeptide Y mRNA concentrations in the rat hypothalamus: NPY may mediate nicotine's effects on energy balance.
    Frankish HM; Dryden S; Wang Q; Bing C; MacFarlane IA; Williams G
    Brain Res; 1995 Oct; 694(1-2):139-46. PubMed ID: 8974638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of energy homeostasis by the NPY system.
    Loh K; Herzog H; Shi YC
    Trends Endocrinol Metab; 2015 Mar; 26(3):125-35. PubMed ID: 25662369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y receptors as targets for anti-obesity drug development: perspective and current status.
    Parker E; Van Heek M; Stamford A
    Eur J Pharmacol; 2002 Apr; 440(2-3):173-87. PubMed ID: 12007534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity therapy: altering the energy intake-and-expenditure balance sheet.
    Crowley VE; Yeo GS; O'Rahilly S
    Nat Rev Drug Discov; 2002 Apr; 1(4):276-86. PubMed ID: 12120279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of physical exercise on orexigenic and anorexigenic peptides and its role on long-term feeding control.
    Benite-Ribeiro SA; Putt DA; Santos JM
    Med Hypotheses; 2016 Aug; 93():30-3. PubMed ID: 27372853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined deletion of Y1, Y2, and Y4 receptors prevents hypothalamic neuropeptide Y overexpression-induced hyperinsulinemia despite persistence of hyperphagia and obesity.
    Lin EJ; Sainsbury A; Lee NJ; Boey D; Couzens M; Enriquez R; Slack K; Bland R; During MJ; Herzog H
    Endocrinology; 2006 Nov; 147(11):5094-101. PubMed ID: 16873543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny of the hypothalamic neuropeptide Y system.
    Grove KL; Smith MS
    Physiol Behav; 2003 Jun; 79(1):47-63. PubMed ID: 12818709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinical perspective on peptides and food intake.
    Hirsch J; Leibel RL; Chua SC
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):296S-298S. PubMed ID: 1728843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide y receptor selective ligands in the treatment of obesity.
    Kamiji MM; Inui A
    Endocr Rev; 2007 Oct; 28(6):664-84. PubMed ID: 17785427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y.
    Erickson JC; Hollopeter G; Palmiter RD
    Science; 1996 Dec; 274(5293):1704-7. PubMed ID: 8939859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of neuropeptides in appetite regulation and obesity--a review.
    Arora S; Anubhuti
    Neuropeptides; 2006 Dec; 40(6):375-401. PubMed ID: 16935329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hypothalamic neuropeptide Y in feeding and obesity.
    Gehlert DR
    Neuropeptides; 1999 Oct; 33(5):329-38. PubMed ID: 10657510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.